IRMD IRadimed Corporation
Platform & Compounding FCF
A 88.4 / 100 composite

AlphaQuality composite grade, weighted for platform & compounding fcf businesses.

Profitability

Weight: 25%
A 92
  • 5yr Avg ROIC 19.3%
  • Operating Margin Trend +1.61 pp/yr

Capital Efficiency

Weight: 15%
B+ 78
  • 5yr Avg ROE 20.1%
  • 5yr Share-Count CAGR 0.7%

Growth Quality

Weight: 25%
A+ 100
  • 5yr Revenue CAGR 21.5%
  • 5yr EPS CAGR 73.9%
  • Revenue-Growth Years (5) 5/5

Cash Generation

Weight: 20%
A- 82
  • 5yr FCF Margin 18.7%
  • 5yr FCF/NI Conversion 0.75x

Balance Sheet

Weight: 10%
A+ 100
  • Net Debt / EBITDA -1.66x
  • Interest Coverage (EBIT/Int) 30.00x
  • Altman Z-Score 47.78

Stability

Weight: 5%
C- 49
  • EPS Volatility (σ/μ) 0.66
  • Negative-Revenue Years (5) 0/5
  • Piotroski F-Score 5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Trimming

1 of 2 gurus held; 1 trimmed; 1 full exit.

Holders
1 -1
Avg Δ position
-16.8%
New buys
0
Full exits
1
As of Q2 2026